Clinical Trials Browser

Ovarian Neoplasms × repaglinide × Clear all

NCT04718740 2023-08-14

A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer

Phase 1 Completed

Ovarian Neoplasms